Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet

With prices in a downtrend with a $95 price target, hold off on purchases until prices hold for the drugmaker.

Sarepta Therapeutics Looks Ready to Break Out to the Upside

Here's how to play this stock.

6 Healthcare Favorites Poised for Second-Half Gains

A check-up on six healthcare ideas that remain favorites for the remainder of 2019.

Ambiomed Stock: A Look Forward

ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.

CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long

All the charts of the molecular diagnostics company look bullish.

Edwards Lifesciences Has Formula for Long-Lasting Rally

EW has had some corrections and pullbacks along the way during this long and strong rally from $80 to nearly $200, but its price target is $240.

Evolus Is Shaping Up Nicely, Time to Go Long

Let's look at the charts and indicators.

Johnson & Johnson: Key Points to Watch on the Charts

The stock has been bouncing off the 200-day moving average line.

Evolus Could Turn Into an Attractive Play

It may pay to keep this one on your future shopping list.